|
|
Volumn 2, Issue 1, 2003, Pages 11-12
|
|
Antithrombotic drug market. Market indicators
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1 [3 (AMINOMETHYL)PHENYL] N [3 FLUORO 2' (METHYLSULFONYL)[1,1' BIPHENYL] 4 YL] 3 (TRIFLUOROMETHYL) 1H PYRAZOLE 5 CARBOXAMIDE;
2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID;
3 [7 [2 (3,4 DIFLUOROPHENYL)CYCLOPROPYLAMINO] 5 PROPYLTHIO 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL] 5 HYDROXYMETHOXY 1,2 CYCLOPENTANEDIOL;
ACETYLSALICYLIC ACID;
ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
AR C 69931;
BB 10153;
BIB 1048MS;
BLOOD CLOTTING FACTOR 10A;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
BLOOD CLOTTING FACTOR 9A;
CLOPIDOGREL;
ENOXAPARIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
FIBRINOLYTIC AGENT;
FONDAPARINUX;
HEPARIN;
IDRAPARINUX;
LOW MOLECULAR WEIGHT HEPARIN;
ODIPARCIL;
PLASMINOGEN ACTIVATOR;
PRASUGREL;
PURINE P2Y RECEPTOR;
RIVAROXABAN;
THROMBIN INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
WARFARIN;
XIMELAGATRAN;
BLEEDING;
CLINICAL TRIAL;
DRUG ACTIVITY;
DRUG BINDING;
DRUG BIOAVAILABILITY;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MARKETING;
DRUG MONITORING;
DRUG SAFETY;
FOOD DRUG INTERACTION;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HUMAN;
ISCHEMIA;
LIVER DYSFUNCTION;
NOTE;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
PRIORITY JOURNAL;
STROKE;
THROMBOEMBOLISM;
ARTICLE;
ECONOMICS;
HEALTH CARE COST;
ORAL DRUG ADMINISTRATION;
UNITED STATES;
ADMINISTRATION, ORAL;
FIBRINOLYTIC AGENTS;
HEALTH CARE SECTOR;
HUMANS;
PLATELET AGGREGATION INHIBITORS;
UNITED STATES;
|
|
EID: 0037267314
PISSN: 14741776
EISSN: None
Source Type: Journal
DOI: 10.1038/nrd966 Document Type: Note |
|
Times cited : (40)
|
|
References (1)
|
